Xencor Inc (XNCR)
Days of sales outstanding (DSO)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 13.76 | 2.89 | 6.17 | 5.30 | 5.59 | 6.69 | 5.37 | 3.92 | 4.38 | 8.85 | 13.40 | 10.22 | 10.06 | 9.54 | 8.18 | 11.33 | 7.56 | 36.83 | 17.20 | 1.16 | |
DSO | days | 26.53 | 126.23 | 59.15 | 68.92 | 65.26 | 54.59 | 68.03 | 93.00 | 83.35 | 41.26 | 27.24 | 35.71 | 36.27 | 38.28 | 44.60 | 32.23 | 48.27 | 9.91 | 21.22 | 315.73 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 13.76
= 26.53
Xencor Inc's days of sales outstanding (DSO) has exhibited fluctuations over the past eight quarters. In Q4 2023, the company's DSO stood at 24.48 days, representing a significant improvement compared to the previous quarter where it was at 138.20 days. This suggests that Xencor Inc was able to collect its accounts receivable more efficiently in Q4 2023.
The DSO for Q2 2023 was 64.44 days, indicating a moderate level of efficiency in collecting receivables during that period. It was lower than in the previous quarter but higher compared to Q4 2022.
However, Q3 2023 saw a notable deterioration in efficiency with DSO soaring to 138.20 days, which might raise concerns about the company's management of accounts receivable and potential liquidity issues.
Comparing the DSO over the past eight quarters, it can be observed that there have been fluctuations in the efficiency of receivables collection. It is recommended for Xencor Inc to closely monitor and manage its accounts receivable to ensure timely collection and maintain a healthy cash flow position.
Peer comparison
Dec 31, 2023